Kobayashi Pharmaceutical Co (TSE:4967) Issuance of Debt: 円0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4967 Kobayashi Pharmaceutical Co Ltd TSE:4967
79 GF Score
Price 円5,679.00
GF Value 円4,885.25
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Kobayashi Pharmaceutical Co Issuance of Debt?

Kobayashi Pharmaceutical Co TSE:4967 -0.98% 79 Issuance of Debt is 円0 Mil as of Jun. 2026. GuruFocus rates TSE:4967 with a GF Score™ of 79/100 and a GF Value™ of 円4,885.25 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Kobayashi Pharmaceutical Co's Issuance of Debt for the three months ended in Jun. 2026 was 円0 Mil.

Kobayashi Pharmaceutical Co's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was 円0 Mil.

Kobayashi Pharmaceutical Co Issuance of Debt Related Terms

Kobayashi Pharmaceutical Co Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Kobayashi Pharmaceutical Co's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co Issuance of Debt Chart

Kobayashi Pharmaceutical Co Annual Data
Trend Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Kobayashi Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4967
79GF Score
Kobayashi Pharmaceutical Co Ltd TSE:4967
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kobayashi Pharmaceutical Co Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of 円0 Mil mean?
Kobayashi Pharmaceutical Co (TSE:4967) has a Issuance of Debt of 円0 Mil as of Jun. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Kobayashi Pharmaceutical Co and its competitors.
Is Kobayashi Pharmaceutical Co's Issuance of Debt too high?
Kobayashi Pharmaceutical Co's current Issuance of Debt is 円0 Mil. Overall, Kobayashi Pharmaceutical Co has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kobayashi Pharmaceutical Co's Issuance of Debt compare to PG and CL?
Kobayashi Pharmaceutical Co's Issuance of Debt of 円0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Consumer Packaged Goods company?
A good Issuance of Debt depends on the Consumer Packaged Goods industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Kobayashi Pharmaceutical Co and its competitors. Kobayashi Pharmaceutical Co's current Issuance of Debt is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobayashi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co (TSE:4967) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,885.25, compared to a current price of 円5,679.00 — trading 16.2% above its estimated fair value. The current Issuance of Debt is 円0 Mil. Kobayashi Pharmaceutical Co's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Kobayashi Pharmaceutical Co (TSE:4967), the current Issuance of Debt is 円0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kobayashi Pharmaceutical Co (TSE:4967) Overvalued in 2026?

Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co stock appears to be overvalued. The current stock price of 円5,679.00 is trading 16.2% above its estimated GF Value™ of 円4,885.25. GuruFocus considers Kobayashi Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for TSE:4967:

  • Issuance of Debt: 円0 Mil
  • GF Value™: 円4,885.25 vs. price of 円5,679.00 (16.2% above fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the TSE:4967 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kobayashi Pharmaceutical Co Business Description

Other Exchanges KOY:Germany
Address 4-4-10 Doshomachi, KDX Kobayashi Doshomachi Building, Chuo-ku, Osaka, JPN, 541-0045
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
79GF Score

Get the complete analysis for TSE:4967

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円5,679.00
Price
円4,885.25
GF Value